Difluprednate (Durezol) is hard to find in 2026 due to ongoing shortages. Learn why this eye drop is scarce and what you can do to get your prescription filled.
You just had eye surgery — or maybe you're managing uveitis — and your doctor prescribed Difluprednate eye drops. You head to the pharmacy, only to hear those dreaded words: "We don't have it in stock."
If this sounds familiar, you're far from alone. Difluprednate, sold under the brand name Durezol, has been increasingly difficult to find since early 2024. Patients across the country have been scrambling to locate pharmacies that carry it, sometimes calling dozens of stores before finding a single bottle.
In this guide, we'll explain exactly what Difluprednate is, why it's been so hard to find, and — most importantly — what you can do about it.
Difluprednate is a prescription ophthalmic corticosteroid — a steroid eye drop used to reduce inflammation and pain in the eye. It's available as a 0.05% ophthalmic emulsion in a 5 mL bottle.
The FDA has approved Difluprednate for two main uses:
Difluprednate is considered one of the most potent ophthalmic steroids available. Ophthalmologists often prefer it because of its strong anti-inflammatory action and its unique emulsion formulation, which doesn't require shaking as vigorously as suspension-based drops like Prednisolone Acetate.
For patients recovering from eye surgery or dealing with uveitis flares, Difluprednate can be essential for preventing complications and preserving vision.
There are several factors working together to make Difluprednate scarce. Here are the main reasons:
The biggest factor is a supply chain disruption that started in April 2024. Exelan, one of the key generic manufacturers of Difluprednate 0.05%, placed its 5 mL bottles on long-term back order with no estimated release date. The American Society of Health-System Pharmacists (ASHP) has tracked this shortage since it began, and as of early 2026, the situation remains unresolved.
When a generic manufacturer goes offline, it puts enormous pressure on the remaining suppliers and on the brand-name product.
Unlike common medications with dozens of generic makers, Difluprednate is a specialized ophthalmic emulsion that's difficult to manufacture. The formulation requires precise emulsification with castor oil and other inactive ingredients, making it harder for new manufacturers to enter the market quickly.
Dr. Reddy's Laboratories launched a generic version, but limited production capacity means supply still can't fully meet demand.
Cataract surgery is one of the most commonly performed procedures in the United States, with over 4 million surgeries per year. Many ophthalmologists prescribe Difluprednate as their go-to post-operative anti-inflammatory drop. That's a lot of demand concentrated on a single medication.
When the generic is unavailable, patients are pushed toward brand-name Durezol, which can cost $250 to $400 per bottle without insurance. Even with insurance, high copays on branded ophthalmic drugs can make it unaffordable, leading some patients to delay or skip treatment — which is especially dangerous after eye surgery.
Don't panic. There are practical steps you can take right now:
Medfinder helps you search for pharmacies that currently have Difluprednate in stock near your location. Instead of calling pharmacy after pharmacy, you can check availability in seconds. Learn more about finding Difluprednate in stock near you.
If Difluprednate truly isn't available anywhere near you, talk to your ophthalmologist about alternative corticosteroid eye drops. Options like Prednisolone Acetate (Pred Forte), Loteprednol Etabonate (Lotemax), or Dexamethasone (Maxidex) may be appropriate depending on your condition.
Chain pharmacies often run out of shortage medications first. Independent pharmacies and compounding pharmacies may have better stock because they source from different wholesalers. Specialty ophthalmic pharmacies can also be a good resource.
If cost is the barrier, there are options. Coupons and patient assistance programs can bring the price down significantly. Generic Difluprednate can be found for as low as $43 to $49 with a discount card from GoodRx or SingleCare.
The Difluprednate shortage is frustrating, especially when you need the medication for something as important as your eye health. But understanding why it's hard to find is the first step toward finding a solution.
The shortage stems from manufacturing disruptions, limited producers, high surgical demand, and pricing barriers. While we wait for supply to stabilize, tools like Medfinder can help you locate available stock, and your eye doctor can work with you on alternatives if needed.
Stay informed by checking our Difluprednate shortage update for 2026 for the latest developments.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
